Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

Cho, H., Gonzales-Wartz, K. K., Huang, D., Yuan M., Peterson, M., Liang, J., Beutler, N., Torres, J. L., Cong, Y., Postnikova, E., Bangaru, S., Talana, C. A., Shi, W., Yang, E. S., Zhang, Y., Leung, K., Wang, L., Peng, L., Skinner, J., Li, S., Wu, N. C., Liu, H., Dacon, C., Moyer,T., Cohen, M., Zhao, M., Lee, F. E., Weinberg, R. S.,Douagi, I., Gross, R., Schmaljohn, C., Pegu, A., Mascola, J. R., Holbrook, M., Nemazee, D., Rogers, T. F.,Ward, A. B., Wilson, I. A., Crompton, P. D., Tan, J.  Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.  Sci. Transl. Med. 2021.  doi: 10.1126/scitranslmed.abj5413

Privacy Preference Center

Necessary

Advertising

Analytics

Other